Ying Chen, Yifan Zhang, Jinxiang Zhang, Jiaqi Wang
{"title":"Significance of myelosuppression in the chemotherapy of early breast cancer","authors":"Ying Chen, Yifan Zhang, Jinxiang Zhang, Jiaqi Wang","doi":"10.3760/CMA.J.ISSN.1006-9801.2020.02.016","DOIUrl":null,"url":null,"abstract":"Chemotherapy has become an important therapy for breast cancer. The myelosuppression is an inevitable adverse reaction during the chemotherapy, as well as a sign of drug effectiveness to some degree. Some retrospective studies have found that the patients with myelosuppression show the better survival in the chemotherapy of early breast cancer. This paper discusses the significance of myelosuppression in the chemotherapy of early breast cancer. \n \n \nKey words: \nBreast neoplasms; Neutropenia; Drug therapy, combination; Myelosuppression","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":"32 1","pages":"137-140"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2020.02.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Chemotherapy has become an important therapy for breast cancer. The myelosuppression is an inevitable adverse reaction during the chemotherapy, as well as a sign of drug effectiveness to some degree. Some retrospective studies have found that the patients with myelosuppression show the better survival in the chemotherapy of early breast cancer. This paper discusses the significance of myelosuppression in the chemotherapy of early breast cancer.
Key words:
Breast neoplasms; Neutropenia; Drug therapy, combination; Myelosuppression
期刊介绍：
"Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association.
It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
